Skip to content Skip to navigation

Enterhealth taps Ling to serve as clinical adviser

April 21, 2015
by Gary A. Enos, Editor
| Reprints

Walter Ling, MD, founding director of Integrated Substance Abuse Programs at UCLA, has joined the advisory board of Dallas-based addiction treatment organization Enterhealth as a clinical adviser.

Ling also serves as principal investigator for the National Institute on Drug Abuse (NIDA) Clinical Trials Network's Pacific Region Node. In his role at Enterhealth, he will work with president Dave Kniffen, Jr., and chief medical strategist Harold Urschel, MD, on program development and clinician training.

Ling is board-certified in neurology and psychiatry and is actively involved in both research and clinical care initiatives.

Topics